Terazosin 5 MG

DRUG2 trials

Sponsors

Jordan Schultz, Nandakumar Narayanan

Conditions

Parkinson DiseaseParkinson's Disease (PD)

Phase 1

A Pilot Study of Terazosin for Parkinson's Disease

CompletedNCT03905811

Jordan SchultzParkinson Disease

Start: 2019-09-24End: 2020-11-18Updated: 2022-05-16

Phase 2

Terazosin And Metabolic Energetics in Parkinson's Disease

Not yet recruitingNCT07464028

Nandakumar NarayananParkinson's Disease (PD)

Start: 2026-07-01End: 2031-07-01Target: 120Updated: 2026-03-16